Skip to main content
. 2015 Apr 10;7(1):42. doi: 10.1186/s13148-015-0076-2

Figure 3.

Figure 3

miR-375 is significantly co-expressed with (A) miR-32 and (B) miR-182 in prostate cancer patients from TCGA (r calculated by Spearman’s correlations).